Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subhendu K Das

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Trends in Cell Biology|August 13, 2022
MYC: a complex problemSubhendu K Das, Brian A Lewis, David Levens
Molecular Cell|October 31, 2024
Excessive MYC-topoisome activity triggers acute DNA damage, MYC degradation, and replacement by a p53-topoisomeSubhendu K Das, Sharmistha Karmakar, Harish Venkatachalapathy, et al.
Nucleic Acids Research|July 29, 2016
Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cellsSubhendu K Das, Ishita Rehman, Arijit Ghosh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 23, 2022
TDP1 knockout Leishmania donovani accumulate topoisomerase 1-linked DNA damage and are hypersensitive to clinically used antileishmanial drugsSomenath Roy Chowdhury, Subhendu K Das, Bijoylaxmi Banerjee, et al.
Elife|July 28, 2020
Dissecting transcriptional amplification by MYCZuqin Nie, Chunhua Guo, Subhendu K Das, et al.
Nucleic Acids Research|May 3, 2018
PRMT5-mediated arginine methylation of TDP1 for the repair of topoisomerase I covalent complexesIshita Rehman, Suparna M Basu, Subhendu K Das, et al.
Journal of Medicinal Chemistry|February 24, 2023
Novel Pyrido[2',1':2,3]imidazo[4,5-<i>c</i>]quinoline Derivative Selectively Poisons <i>Leishmania donovani</i> Bisubunit Topoisomerase 1 to Inhibit the Antimony-Resistant <i>Leishmania</i> Infection <i>in Vivo</i>Srijita Paul Chowdhuri, Shiv Dhiman, Subhendu K Das, et al.
European Journal of Medicinal Chemistry|July 19, 2020
Development of a metabolically stable topoisomerase I poison as anticancer agentBiswajit Kundu, Dipayan Sarkar, Srijita Paul Chowdhuri, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Dynamic Supercoiling Sponsors Transcription Amplification by MYCRajiv Kumar Jha, Fedor Kouzine, Bo Wang, et al.
European Journal of Medicinal Chemistry|August 28, 2015
Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activityPapiya Majumdar, Chandramohan Bathula, Suparna M Basu, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Trends in Cell Biology|August 13, 2022
MYC: a complex problemSubhendu K Das, Brian A Lewis, David Levens
Molecular Cell|October 31, 2024
Excessive MYC-topoisome activity triggers acute DNA damage, MYC degradation, and replacement by a p53-topoisomeSubhendu K Das, Sharmistha Karmakar, Harish Venkatachalapathy, et al.
Nucleic Acids Research|July 29, 2016
Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cellsSubhendu K Das, Ishita Rehman, Arijit Ghosh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 23, 2022
TDP1 knockout Leishmania donovani accumulate topoisomerase 1-linked DNA damage and are hypersensitive to clinically used antileishmanial drugsSomenath Roy Chowdhury, Subhendu K Das, Bijoylaxmi Banerjee, et al.
Elife|July 28, 2020
Dissecting transcriptional amplification by MYCZuqin Nie, Chunhua Guo, Subhendu K Das, et al.
Nucleic Acids Research|May 3, 2018
PRMT5-mediated arginine methylation of TDP1 for the repair of topoisomerase I covalent complexesIshita Rehman, Suparna M Basu, Subhendu K Das, et al.
Journal of Medicinal Chemistry|February 24, 2023
Novel Pyrido[2',1':2,3]imidazo[4,5-<i>c</i>]quinoline Derivative Selectively Poisons <i>Leishmania donovani</i> Bisubunit Topoisomerase 1 to Inhibit the Antimony-Resistant <i>Leishmania</i> Infection <i>in Vivo</i>Srijita Paul Chowdhuri, Shiv Dhiman, Subhendu K Das, et al.
European Journal of Medicinal Chemistry|July 19, 2020
Development of a metabolically stable topoisomerase I poison as anticancer agentBiswajit Kundu, Dipayan Sarkar, Srijita Paul Chowdhuri, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Dynamic Supercoiling Sponsors Transcription Amplification by MYCRajiv Kumar Jha, Fedor Kouzine, Bo Wang, et al.
European Journal of Medicinal Chemistry|August 28, 2015
Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activityPapiya Majumdar, Chandramohan Bathula, Suparna M Basu, et al.
Pageof 2